RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyundai Bioscience Co Stock

Hyundai Bioscience Co Debt 2024

Hyundai Bioscience Co Debt

0 KRW

Ticker

048410.KQ

ISIN

KR7048410005

In 2024, Hyundai Bioscience Co's total debt was 0 KRW, a -100% change from the 3,516.52 KRW total debt recorded in the previous year.

Hyundai Bioscience Co Aktienanalyse

What does Hyundai Bioscience Co do?

Hyundai Bioscience Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Hyundai Bioscience Co's Debt Structure

Hyundai Bioscience Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Hyundai Bioscience Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Hyundai Bioscience Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Hyundai Bioscience Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Hyundai Bioscience Co stock

What is the debt of Hyundai Bioscience Co this year?

Hyundai Bioscience Co has a debt level of 0 KRW this year.

What was the debt of Hyundai Bioscience Co compared to the previous year?

The debt of Hyundai Bioscience Co has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Hyundai Bioscience Co?

High debt can pose a risk for investors of Hyundai Bioscience Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Hyundai Bioscience Co?

Low debt means that Hyundai Bioscience Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Hyundai Bioscience Co affect the company?

An increase in debt of Hyundai Bioscience Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Hyundai Bioscience Co affect the company?

A reduction in debt of Hyundai Bioscience Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Hyundai Bioscience Co?

Some factors that can influence the debt of Hyundai Bioscience Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Hyundai Bioscience Co so important for investors?

The debts of Hyundai Bioscience Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Hyundai Bioscience Co take to change the debt?

To change the debt, Hyundai Bioscience Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Hyundai Bioscience Co pay?

Over the past 12 months, Hyundai Bioscience Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyundai Bioscience Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Hyundai Bioscience Co?

The current dividend yield of Hyundai Bioscience Co is .

When does Hyundai Bioscience Co pay dividends?

Hyundai Bioscience Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyundai Bioscience Co?

Hyundai Bioscience Co paid dividends every year for the past 0 years.

What is the dividend of Hyundai Bioscience Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyundai Bioscience Co located?

Hyundai Bioscience Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Hyundai Bioscience Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyundai Bioscience Co from 4/13/2004 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2003.

When did Hyundai Bioscience Co pay the last dividend?

The last dividend was paid out on 4/13/2004.

What was the dividend of Hyundai Bioscience Co in the year 2023?

In the year 2023, Hyundai Bioscience Co distributed 0 KRW as dividends.

In which currency does Hyundai Bioscience Co pay out the dividend?

The dividends of Hyundai Bioscience Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyundai Bioscience Co

Our stock analysis for Hyundai Bioscience Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyundai Bioscience Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.